Coronary Revascularization in Diabetic Chronic Kidney Disease/End-Stage Renal Disease

Diagnosis and Management of Cardiovascular Disease in Advanced and End‐Stage Renal Disease

“…This type of stent confers the benefit of a DES with an improved safety profile over a BMS, with the additional advantage of a short course of DAPT, which may be ideal for patients with ESRD 61. Aggressive medical therapy is also an option, given the high restenosis rates in patients with CKD and ESRD 62, 63, 64. These risks must be weighed against the observed improved survival rate after PCI versus medical therapy alone in patients with ESRD 65…”

Long-Term Clinical Outcome After Surgical or Percutaneous Coronary Revascularization in Hemodialysis Patients

“…23, 24 Although no guidelines regarding coronary revascularization are specific for HD patients with CAD, CABG is recommended for HD patients with multi-vessel (or left main trunk) disease and impaired left ventricular function. 25 In this situation, the present findings may contribute to the decision of choice for revascularization procedures in chronic HD patients.…”

10.5937/mckg48-4123 = Diastolic heart failure in patients on hemodialysis: Etiopathogenesis, diagnostics and therapy

“…Prema nalazu koronarografije bolesnici koji se leče hemodijalizom mogu se podeliti u dve grupe: sa visokim rizikom za razvoj akutnog koronarnog sindroma (koronarna arterijska bolest glavne leve koronarne arterije, trosudovna bolest -ateroskleroza sva tri kronarna arterijska krvna suda, umereni simptomi i smanjena funkcija leve komore, dvosudovna bolest sa zahvatanjem proksimalnog dela leve koronarne arterije) i sa niskim rizikom za razvoj akutnog koronarnog sindroma (jednosudovna bolest -zahvaćenost samo jednog koronarnog krvnog suda i dobra funkcija miokarda) (52)(53)(54). Kod bolesnika sa visokim rizikom CABG (coronary artery by pass grafting) smanjuje rizik od akutnog koronarnog sindroma, a kod bolesnika sa niskim rizikom primenjuje se lečenje medikamentima i perkutana transluminalna angioplastika (PTCA) ili ugradnja stenta -CAS (coronary artery stenting) (52)(53)(54). Implantabilni kardioverter defibrilator ugrađuje se kod bolesnika koji se leče ponavljanim hemodijalizama, kod kojih je ejekciona frakcija leve komore (EFLK) < 35% i koji su preživeli srčani zastoj izazvan komorskim poremećajima srčanog ritma (ventrikularna tahikardija / ventrikularna fibrilacija) (55 …”